Literature DB >> 566867

Epidemiology of Guillain-Barré syndrome.

D Soffer, S Feldman, M Alter.   

Abstract

From 1969 through 1972, a nationwide search for cases of Guillain-Barré syndrome (GBS) is Israel revealed 89 patients. The average annual age-adjusted incidence was 0.75 per 10(5) persons. Overall incidence of the syndrome was similar in Jewish groups of diverse ethnic backgrounds. Arabs had a lower overall incidence than Jews (0.46 per 10(5) persons), perhaps attributable to fewer Arabs at risk in older age groups. Peaks of incidence occurred among individuals over 60 and under 4 years of age when all cases were combined. No clear seasonal or geographic clustering of GBS was evident in Israel during the 4 years of this study. The incidence of GBS in the present study agrees with previous population-based estimates.

Entities:  

Mesh:

Year:  1978        PMID: 566867     DOI: 10.1212/wnl.28.7.686

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients.

Authors:  R K Lyu; L M Tang; S Y Cheng; W C Hsu; S T Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Guillain-Barré syndrome in Stockholm County, 1973-1991.

Authors:  G X Jiang; Q Cheng; A Ehrnst; H Link; J de Pedro-Cuesta
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

Review 3.  Immunology of Guillain-Barré syndrome.

Authors:  I Steiner; O Abramsky
Journal:  Springer Semin Immunopathol       Date:  1985

4.  The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally.

Authors:  Ramona Aronovich; Aviva Katzav; Joab Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

5.  The epidemiology of inflammatory polyradiculoneuropathy. A critical review of the distribution, characteristics and outcome of the disease. Plasmapheresis Study Group.

Authors:  E Beghi; F Cornelio; M Marconi; N Rizzuto; P Tonali
Journal:  Ital J Neurol Sci       Date:  1991-02

6.  Treatment for experimental autoimmune neuritis with clodronate (Bonefos).

Authors:  Aviva Katzav; Hofit Bina; Ramona Aronovich; Joab Chapman
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

7.  North West Thames registry of neurological disease.

Authors:  S Haberman; B Benjamin; R Capildeo; F C Rose
Journal:  J R Soc Med       Date:  1982-06       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.